| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 39.9444 | 6 |
| GSM780708 | Untreated after 4 days (C2_1) | 43.5918 | 20 |
| GSM780709 | Untreated after 4 days (C3_1) | 43.0339 | 18 |
| GSM780719 | Untreated after 4 days (C1_2) | 48.1222 | 42 |
| GSM780720 | Untreated after 4 days (C2_2) | 46.7558 | 36 |
| GSM780721 | Untreated after 4 days (C3_2) | 46.6279 | 35 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 44.6662 | 25 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 44.1312 | 23 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.5182 | 30 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 44.7531 | 26 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 46.7946 | 36 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 44.7878 | 26 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 41.3316 | 11 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 37.5804 | 2 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 43.8218 | 21 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 43.9755 | 22 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 40.2317 | 7 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 45.7627 | 31 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 44.1438 | 23 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 42.4607 | 15 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 40.4671 | 8 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 46.9637 | 37 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 40.1631 | 7 |